Researchers have honed in on a class of genes that are methylated on only the maternal allele at conception, but that follow slightly different rules than imprinted genes. This emerging class of genes seems to mainly affect two key parts of the body: the brain and the testis.
Imprinted genes usually follow a set pattern of methylation, being methylated at conception on either the paternal or maternal DNA. The most common pattern of imprinting involves methylation on the maternal allele inherited from the oocyte, with an unmethylated paternal allele coming from the sperm. All non-imprinted genes were thought to be stripped of methyl marks shortly after fertilization, removing any differential methylation inherited from the parents, but imprinted genes retain their methyl marks.
Charlotte Rutledge and Avinash Thakur et al. examined a class of non-imprinted genes that also inherit methylation on the maternal allele from the oocyte-and retain this differential mark in early embryogenesis. In contrast to imprinted genes, these genes acquire methylation on the paternal allele as well, shortly after implantation, erasing the differences between maternal and paternal alleles.
The researchers have found that this class of genes falls into two major groups: one expressed primarily in the testis and the other in the brain. The testis-specific genes were methylated mainly on promoters, and lost methylation in the testis, resulting in gene transcription. The brain-specific genes were methylated primarily in the coding regions, and it is unclear what role methylation plays in their regulation. Previous studies have hinted at a role in regulation of splicing.
Although most of the experiments were performed in mice or mouse cells, the results seem to be applicable to humans. For instance, the locations of these so-called gametic differentially methylated regions (gDMRs) were conserved in human cells, as were their methylation levels. The researchers also identified some of the enzymes that establish and maintain the gDMRs, such as the methyltransferase Dnmt3l.
The largest class of gDMR genes identified (several hundred) were expressed in the brain, while the other major class was expressed in the testes. Since these latter gDMRs are focused on promoter regions expected to be regulatory and are susceptible to pharmacological manipulation, they may be particularly sensitive to environmental exposures that affect methylation. Several recent studies peer deep into the mechanics of meiosis, identifying components of several key molecular complexes and showcasing similarities and differences with mitosis.
Several mechanisms assure proper chromosome pairing and alignment during meiosis. One is attachment of telomeres to the nuclear envelope and their repositioning as meiosis progresses. Jana Link et al. [1] show how a protein called SUN2 (Sad-1/Unc-84) helps mediate this tethering during male and female meiosis in mice. SUN2 operates in conjunction with SUN1, which has at least partially redundant functions. Both SUN1 and SUN2 are components of a protein complex that spans the nuclear membrane: the LINC (linker of nucleoskeleton and cytoskeleton) complex. LINC complexes function in both dividing and nondividing cells, and have broader roles, such as maintaining nuclear shape.
Another key protein complex necessary for proper meiosis is the chromosomal passenger complex. In both mitosis and meiosis, this complex regulates multiple aspects of chromosome segregation, including the spindle assembly checkpoint and cytokinesis. The catalytic component of this complex is AURKB (aurora B kinase). Ahmed Z. Balboula and Karen Schindler [2] took a close look at AURKC, an AURKB homolog that is expressed in germ cells. They found that AURKB and AURCKC seem to have distinct functions during meiosis. The unique tasks of AURKC include regulating chromosome alignment and kinetochore-microtubule attachment at metaphase of meiosis I (Fig. 1) .
In a third study, Laetitia Martinerie et al. [3] dissected the meiotic role for E type cyclins, which have major roles in mitosis. They found that cyclin E1 and E2 seem to assure proper progression of spermatocytes through meiotic prophase I. In spermatocytes, cyclin E1 and E2 also associate with their known partner, CDK2, which is localized at telomeres. Improper telomere positioning and functioning may underlie some of the defects observed in spermatocytes depleted of these cyclins, including aberrant chromosome pairing and synapsis.
Kei-ichiro Ishiguro et al. [4] examined how homologous chromosomes recognize each other and pair up. The process is thought to involve multiple cellular processes, including telomere attachment and DNA double-stranded breakage. In the new study, the researchers found a central role for RAD21L, a meiosis-specific cohesin. The canonical role for cohesins is in sister-chromatid cohesion, keeping identical chromosomes stuck together during mitosis and meiosis. The new findings suggest that the major role of RAD21L is instead in homolog pairing and synapsis; experiments in spermatocytes suggested that it may operate at the earliest stages of this process. RAD21L may help the chromosomes associate and pair up properly, the researchers speculate, perhaps through a mechanism involving homology in chromosome architecture.
When the various molecular systems that power meiosis fail to function properly, the result is often infertility or aberrant embryonic and fetal development. A recent study by Eric Vilain and colleagues [5] brings this message home. The researchers identified mutations in STAG3 (stromal antigen 3) in a family with premature ovarian failure, and they reported that it encodes a meiosis-specific subunit of the cohesin complex. Fetal oocytes of mice deficient in Stag3 were arrested at early prophase I, leading to oocyte depletion-a phenotype similar to that observed in humans. According to a new study, a protein expressed by blood vessels in the mature brain directs the growth of neuronal axons that produce a key trigger for ovulation: gonadotropin-releasing hormone (GnRH). This axonal growth assures that GnRH neurons release a surge of this neurohormone into the correct location-a vascular portal allowing transit of the neurohormone to key endocrine cells in the pituitary gland. As a result, the pituitary gland releases luteinizing hormone (LH), which in turn prompts ovulation.
GnRH is produced in the hypothalamus, and it reaches the pituitary through a specialized portal system, a network of capillaries that connects the two structures. GnRH neurons extend their axons close to these capillaries to permit the massive release of GnRH just prior to ovulation. Semaphorin 3A is known to be expressed in vascular endothelial cells and also to affect the guidance of axons. Previous studies have hinted that it may also have a role in the development of the GnRH neuronal system. For instance, mutations in semaphorin 3A result in impaired migration of GnRH neurons during embryonic development; people with such mutations have Kallman syndrome, characterized by GnRH deficiency and hypogonadism.
In the new study, Paolo Giacobini et al. carefully dissected the role of semaphorin 3A in ovulation. The researchers found that inhibiting either semaphorin 3A or its receptor, Nrp1, in an in vitro system prevented axonal sprouting of GnRH neurons. Several in vivo experiments also supported a role for these molecules. For instance, infusing antibodies to semaphorin or NRP1 into the brains of rats disrupted the ovarian cycle. Similarly, selectively neutralizing semaphorin 3A signaling in endothelial cells near GnRH neurons inhibited the production of LH in mice. The researchers also provided evidence that a rise in semaphorin expression prior to ovulation is induced by estrogen.
The findings shine light on an exquisite regulatory system that triggers ovulation. At the right place and time, expression of semaphorin 3A directs GnRH-secreting axons to sprout and interact with blood vessels that will carry this key hormone to its destination in the pituitary gland. The uterine environment can be a dangerous place for sperm. New findings in mice show that sperm shield themselves with a protein abundant in the seminal fluid, SVS2 (seminal vesicle secretion 2). Without this protein, sperm die in the uterus.
SVS2, which has homologs in many species, has previously been implicated in sperm fertility in mice. SVS2 binds to sperm in the uterus, and in vitro the protein affects sperm fertility. To find out how this protein operates in vivo, Natsuko Kawano et al. [1] created mice lacking the SVS2 gene. Males had extremely poor fertility, and the females they mated with failed to form a copulatory plug, a structure in mice that prevents sperm leakage from the uterus.
It is known that mice lacking a copulatory plug can be fertile, so the researchers looked elsewhere to explain the infertility of SVS2-deficient mice. After finding that most of the sperm produced by these animals died in the uterus, the researchers went on to show that uterine fluid could kill both SVS2 wild-type and SVS2-deficient sperm when unprotected by seminal fluid. Fluid from the oviduct did not have this effect.
Seminal fluid has a range of functions, such as providing an energy source for sperm, causing contractions of the female reproductive tract, and preparing the uterine environment for implantation. A recent study by John Bromfield et al. [2] even suggested that seminal fluid affects the metabolism of the offspring via an epigenetic mechanism.
Kawano et al. suggest that SVS2 may have evolved in response to sperm selection in the uterus, counteracting a system designed to assure the survival of the fittest sperm. Alternatively, SVS2 may have evolved to shield sperm from the uterus' defense against foreign agents, including microbes for sexually transmitted diseases.
